2m 2m 2m 2m 2m 2m 2m
EQUILLIUM (EQ)
NASDAQ
$3.13+$0.34 (+12.22%)
Price as of Jun 03, 2026 7:53 PM EDT- $183.4MMarket Cap
- 681.51%1-Year Change
- BiotechnologyIndustry
EQUILLIUM (EQ)
$3.13+$0.34 (+12.22%)
EQ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.79 | ||
Change | -$0.29 (-9.42%) | ||
Open | $2.65 | ||
High | $2.99 | ||
Low | $2.23 | ||
Previous Close | $3.08 | ||
Volume | 2,771,729 | ||
30-Day Average Volume | 758,192 | ||
1-Week Change | 20.26% | ||
1-Month Change | 34.13% | ||
1-Year Change | 681.51% | ||
3-Year Change | 343.00% | ||
5-Year Change | -57.27% | ||
Fundamentals | |||
Shares Outstanding | 63.2M | ||
Total Assets | $63.1M | ||
Market Cap | $183.4M | ||
Enterprise Value | $122.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $58.9M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -48 | ||
PEG | 1 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 06/12/2009 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue